CEASE Overdose Act of 2023

Continuous and Enduring Action to Stop Every Overdose Act of 2023 or the CEASE Overdose Act of 2023

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.

The CEASE Overdose Act of 2023, also known as Bill 118 hr 1580, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the ongoing opioid crisis in the United States by providing funding and resources to help prevent overdoses and save lives.

One key aspect of the CEASE Overdose Act is the establishment of a grant program that would provide funding to states and local communities to support overdose prevention efforts. This could include initiatives such as expanding access to naloxone, a medication that can reverse the effects of an opioid overdose, as well as increasing education and awareness about the dangers of opioid use.

Additionally, the bill aims to improve data collection and reporting on overdoses in order to better understand the scope of the problem and target resources where they are most needed. This could help identify trends and patterns in overdose deaths, leading to more effective prevention strategies. Overall, the CEASE Overdose Act of 2023 is a bipartisan effort to address the devastating impact of the opioid crisis in the United States. By providing funding and resources for overdose prevention efforts, this bill has the potential to save lives and make a meaningful impact on communities across the country.